Cisplatin resistance in germ cell tumours: models and mechanisms. - Wikidata - wikimedia - TriplyDB

Cisplatin resistance in germ cell tumours: models and mechanisms.

Cisplatin resistance in germ cell tumours: models and mechanisms.

http://www.wikidata.org/entity/Q38302534

about

Culture at a Higher Temperature Mildly Inhibits Cancer Cell Growth but Enhances Chemotherapeutic Effects by Inhibiting Cell-Cell Collaboration.Depletion of the cisplatin targeted HMGB-box factor UBF selectively induces p53-independent apoptotic death in transformed cells.The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naïve patients with germ cell cancer.Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.Emerging Therapeutic Targets for Male Germ Cell Tumors.Guanidine Alkaloids from the Marine Sponge Monanchora pulchra Show Cytotoxic Properties and Prevent EGF-Induced Neoplastic Transformation in Vitro.Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells.Postchemotherapy changes in testicular germ cell tumours: biology and morphology.Anti-migratory activity of marine alkaloid monanchocidin A - proteomics-based discovery and confirmation.Investigational targeted therapies for the treatment of testicular germ cell tumors.Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization.Platinum-refractory germ cell tumors: an update on current treatment options and developments.Will Testicular Germ Cell Tumors Remain Untargetable?Genomic evolution and chemoresistance in germ-cell tumours.MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.L1-CAM is commonly expressed in testicular germ cell tumours.

P2860

Q35818565-302679E4-9B56-4B8F-A4C5-B1FE03426529 Q36413821-2D6ABB32-CD86-48BB-A526-8FF2EDFAA1B4 Q37689056-202AB1F1-3103-4275-BB48-9778FD51D26F Q38261332-10B314A8-8C5A-45AE-8386-57EA0108C9D8 Q38602699-89B71AC5-0B56-4053-8AD1-E13ACA6E3866 Q38757470-F96E6DE6-EF4F-495C-B989-C659CB3E8380 Q38757753-02EC9385-ACF6-453B-B001-626D4A424563 Q38783396-CAC3FEDF-3007-4B9D-9560-623619EC515A Q38784326-52521742-356B-45E8-A54B-8FCB35461C18 Q38861307-D51FF245-E79A-420E-B567-4DA6D64B1619 Q38861914-F0AE5391-C508-451B-ACCC-0440FA01595E Q38906007-3944538B-C9CA-43BC-A7FE-23BABD46E904 Q39762519-B7761480-A540-46D3-A8EE-C5A31E78A72F Q40447381-D246E9ED-1560-4530-8830-192A9860D454 Q41612255-7513C4F8-4187-4A9E-B273-8FDC940D1F07 Q51820656-CCD90093-69A5-4D7E-A615-F86CD3415249 Q53159544-1886A86D-11F4-4BA6-8042-6B6107674331

P2860

Cisplatin resistance in germ cell tumours: models and mechanisms.

http://www.wikidata.org/entity/Q38302534

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Cisplatin resistance in germ cell tumours: models and mechanisms.

@en

type

label

Cisplatin resistance in germ cell tumours: models and mechanisms.

@en

prefLabel

Cisplatin resistance in germ cell tumours: models and mechanisms.

@en

P1433

Q38302534-9DD0259B-F410-4572-86E3-DC18A99A5B9D

P1476

Q38302534-DB4CF91E-261B-4A81-BB33-0803D06491EE

P2093

Q38302534-1BE771AF-54A4-4DEB-B235-8122FF9B6403

Q38302534-C39FA4A9-D2B3-4F57-8380-E0F8EEE225C0

P2860

Q38302534-01793A79-69DE-4489-8FB8-87518E42BF56

Q38302534-0265F954-940B-4AB1-9480-082503903098

Q38302534-06F7A220-C2DC-44D5-A1B3-355EBB61B531

Q38302534-0DFFDD29-2962-41A7-87E0-9D6BE470C7FE

Q38302534-11DA7926-58A2-443B-9CA2-F2A31B7BADC6

Q38302534-17ED0619-EC6C-4BAC-B720-C56C0CFCBA66

Q38302534-1AD8A8E6-1D5F-4F43-9928-EE8C515FD9C1

Q38302534-27DD2B25-5881-46ED-AE7E-321BF01D9190

Q38302534-2C205F6D-E347-495B-BF6A-D0CDE7D67612

Q38302534-2CF7D615-21CD-4173-8F09-7CD6B806FAFA

P304

Q38302534-91B1A089-44B5-4EB9-B10C-3542C1C2CDB1

P31

Q38302534-7757B110-DFD0-4CF1-8D1E-A51BF0915CD5

P356

Q38302534-7A176C72-3570-48A2-BFDC-2E26DB62C57F

P433

Q38302534-17A6A610-0463-4735-AB8F-DE3C5A48E59E

P478

Q38302534-45737DFD-0B41-400F-ACF6-42CDAB958E6C

P577

Q38302534-868328D5-8E2C-4ACB-8CCC-FB45F3704BF4

P698

Q38302534-21527421-0CB2-4040-AA7F-90DD16237D10

P356

P1433

P1476

Cisplatin resistance in germ cell tumours: models and mechanisms.

@en

P2093

C Jacobsen

http://www.w3.org/2001/XMLSchema#string

F Honecker

http://www.w3.org/2001/XMLSchema#string

P2860

Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors

Systems biology of cisplatin resistance: past, present and future

A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors

p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.

Role of P53 and MDM2 in treatment response of human germ cell tumors.

Xeroderma pigmentosum group a protein and chemotherapy resistance in human germ cell tumors.

Elevation of XPA protein level in testis tumor cells without increasing resistance to cisplatin or UV radiation.

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.

Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.

Survival responses of human embryonic stem cells to DNA damage.

P304

111-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANDR.299

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25546083

http://www.w3.org/2001/XMLSchema#string